Feedback Share Discussion Threads

[ducatiman] 30/5/2018 16:19

I believe that LR2 but I am wondering where TB is? I think the mms are doing same.

[lr2] 30/5/2018 16:15

Still not reached the price Simon Sturge paid awhile back. Plenty to go yet.

[ducatiman] 30/5/2018 15:56

I wonder LR2!?

[lr2] 30/5/2018 15:46

2.8886p (500k) - 3.0926p (100k)

[lr2] 30/5/2018 15:25

2.8886p (500k) - 3.048p (15k)

[lr2] 30/5/2018 11:47

2.8336p (500k) - 2.9975p (150k)

[ducatiman] 30/5/2018 11:26

Buy order, has to be. TB choosing his moments!

[lr2] 30/5/2018 10:49

2.8336p (500k) - 2.9476 (280k). Better buy prices for smaller amounts e.g. 2.9p (100k).

[ducatiman] 30/5/2018 10:41

Tic toc 1.7m

[ducatiman] 29/5/2018 18:20

2m to go is my estimate and mms filling a large buy order imho.

[ducatiman] 29/5/2018 12:26

Hmmm, I'll have a think LR2.

[lr2] 29/5/2018 12:09

Running out of radiologists in Scotland. Any ideas on speeding up workflow Duc?

[gisjob2] 27/5/2018 19:52

bobd29, I agree. Physiomics software predicts the effect of treatment regimes, so is different.

[bobd29] 27/5/2018 16:09

Hi gisjob2, my very basic understanding is that the real strength of TexRAD is its ability to look at the textural density of detected tumours enabling radiologists to obtain information on a tumour that is not visible to the human eye, leading to better diagnosis and treatment requirements. In some/many cases it may determine whether biopsies are needed. Generally time, and money, should be saved and treatment would be more case specific....a win win. Just my understanding at a VERY basic level, dyor.

[ducatiman] 27/5/2018 15:53

Pyc may not be needed as fdbk will have spotted the tumour so early! Seriously though, both will be contributing vastly to cancer survival rates.

[gisjob2] 27/5/2018 14:37

Can't see it's similar at all. Virtual Tumour predicts tumour progression for various treatment regimes. TexRAD Lung is diagnostic software that spots the presence of cancer that may be missed by the human eye.

[hughmar] 27/5/2018 07:39

What impact do you think Physiomics plc will have on the share price of Feedback if any?

Physiomics plc launch 31st May 2018 doing similar work
Physiomics' Virtual Tumour is a sophisticated computer model that simulates tumour cell division and predicts the effect of different anti-cancer regimes to support pre-clinical and clinical oncology development programs. Virtual Tumour helps customers to balance efficacy and toxicity and to prioritise the most effective drug combinations while reducing time and cost.

[ducatiman] 25/5/2018 20:20

Certainly under 3m now, maybe 2.5m. A week or two!!

[lr2] 25/5/2018 14:10

Yes, I can think of a few reasons but you should do your own research.

To get you started:

Feedback already working with GE Healthcare in China.



Feedback already working with Siemens in South Korea.



Feedback already working with Alliance Medical.



"Radiologists don't want to use software that adds to reporting time." - Feedback working with Nvidia to provide rapid response for TexRAD users whilst reducing costs.



I've got lots more than that but it's a starter for you. As for TB, he's just a truculent old man who lost his job on the board and probably his access to inside info along with it. He is irrelevant going forward.

[smithie6] 25/5/2018 13:56

is there any reason to buy here...if one of the 2 big funders TB of developing the technology is selling hard ?!!

[ashtree2] 25/5/2018 13:10

just been quoted 3.5 for 5000 shares online

[gymratt] 25/5/2018 13:03

;@) looking coiled and ready to go..